GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Cost of Revenue (2009 - 2014)

Updated

Analysis

GT Biopharma (GTBP) Cost of Revenue (2009 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 8.10 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 4.29 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.57 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.03 Bn
10 GT Biopharma 6.65 Mn -16.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 5,000.00
Jun 30, 2014 17,000.00
Dec 31, 2013 22,000.00
Sep 30, 2013 123,000.00
Jun 30, 2013 123,000.00
Mar 31, 2013 69,000.00
Dec 31, 2012 61,000.00
Sep 30, 2012 32,000.00
Mar 31, 2012 1,000.00
Sep 30, 2011 8,000.00
Jun 30, 2011 15,000.00
Mar 31, 2011 25,000.00
Dec 31, 2010 65,000.00
Dec 31, 2009 26,000.00
Sep 30, 2009 3,000.00
Jun 30, 2009 20,000.00
API Access

GT Biopharma Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GTBP&period=max&api_key=YOUR_API_KEY